FDA orphan drug designation: treatment of pancreatic cancer
All entries for: Hangzhou Zhongmei Huadong Pharmaceutical Co.
December 10, 2025
Hangzhou Zhongmei Huadong Pharmaceutical Co.
Orphan Drug Designation
Disease Area: Rare Diseases
December 9, 2025
Hangzhou Zhongmei Huadong Pharmaceutical Co.
Orphan Drug Designation
FDA orphan drug designation: treatment of gastric cancer, including gastroesophageal junction cancer
Disease Area: Rare Diseases